“Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s471. doi:10.25251/skin.8.supp.471.